Bortezomib
Bortezomib ((1R,2S)-Bortezomib)
Cat. No: CL-BTZ-01
CAS No: 179324-69-7
Mol. F: C19H25BN4O4
Mol. Wt: 384.2
Inv. Status: Custom Synthesis
Bortezomib Impurity (R,R-Isomer)
Cat. No: CL-BTZ-02
CAS No: 1132709-15-9
Mol. F: C19H25BN4O4
Mol. Wt: 384.2
Inv. Status: Custom Synthesis
Bortezomib Impurity (1S,2R - Isomer)
Cat. No: CL-BTZ-03
CAS No: 1132709-16-0
Mol. F: C19H25BN4O4
Mol. Wt: 384.3
Inv. Status: Custom Synthesis
Bortezomib Impurity (S,S-Isomer)
Cat. No: CL-BTZ-04
CAS No: 1132709-14-8
Mol. F: C19H25BN4O4
Mol. Wt: 384.2
Inv. Status: Custom Synthesis
Bortezomib Impurity 2 (RR-Isomer)
Cat. No: CL-BTZ-06
CAS No: NA
Mol. F: C19H24N4O3
Mol. Wt: 356.4
Inv. Status: Custom Synthesis
Bortezomib Impurity 2 (Mixture Of (1S,2R)-Isomer And (1R,2R)-Isomer)
Cat. No: CL-BTZ-07
CAS No: 2747958-64-9
Mol. F: C19H24N4O3
Mol. Wt: 356.4
Inv. Status: Custom Synthesis
Bortezomib Impurity 3
Cat. No: CL-BTZ-08
CAS No: 2748159-75-1
Mol. F: C14H14N4O2
Mol. Wt: 270.3
Inv. Status: Custom Synthesis
Bortezomib Impurity 4
Cat. No: CL-BTZ-09
CAS No: 862894-96-0
Mol. F: C19H22N4O3
Mol. Wt: 354.4
Inv. Status: Custom Synthesis
Bortezomib Impurity 5
Cat. No: CL-BTZ-10
CAS No: 2379402-85-2
Mol. F: C19H22N4O4
Mol. Wt: 370.4
Inv. Status: Custom Synthesis
Bortezomib Impurity 6
Cat. No: CL-BTZ-11
CAS No: NA
Mol. F: C19H25BN4O5
Mol. Wt: 400.3
Inv. Status: Custom Synthesis
Bortezomib Impurity 7
Cat. No: CL-BTZ-12
CAS No: NA
Mol. F: C10H16BN3O3
Mol. Wt: 237.1
Inv. Status: Custom Synthesis
Bortezomib Impurity 8
Cat. No: CL-BTZ-13
CAS No: NA
Mol. F: C24H27BN6O5
Mol. Wt: 490.3
Inv. Status: Custom Synthesis
Bortezomib Impurity 9
Cat. No: CL-BTZ-14
CAS No: 1194235-41-0
Mol. F: C28H34BN5O5
Mol. Wt: 531.4
Inv. Status: Custom Synthesis
Bortezomib Impurity 10
Cat. No: CL-BTZ-15
CAS No: 390800-88-1
Mol. F: C57H69B3N12O9
Mol. Wt: 1098.7
Inv. Status: Custom Synthesis
Bortezomib Impurity 11
Cat. No: CL-BTZ-16
CAS No: 862895-00-9
Mol. F: C19H22N4O2
Mol. Wt: 338.4
Inv. Status: Custom Synthesis
Bortezomib Impurity 14
Cat. No: CL-BTZ-17
CAS No: 205393-22-2
Mol. F: C29H39BN4O4
Mol. Wt: 518.5
Inv. Status: Custom Synthesis
Bortezomib Impurity 17
Cat. No: CL-BTZ-20
CAS No: NA
Mol. F: C19H25BN4O5
Mol. Wt: 400.3
Inv. Status: Custom Synthesis
Bortezomib Impurity 18
Cat. No: CL-BTZ-21
CAS No: NA
Mol. F: C38H46N8O6
Mol. Wt: 710.8
Inv. Status: Custom Synthesis
Bortezomib Impurity 20
Cat. No: CL-BTZ-23
CAS No: 89618-77-9
Mol. F: C14H24BClO2
Mol. Wt: 270.6
Inv. Status: Custom Synthesis
Bortezomib Impurity 21
Cat. No: CL-BTZ-24
CAS No: 94242-79-2
Mol. F: C20H42BNO2Si2
Mol. Wt: 395.6
Inv. Status: Custom Synthesis
Bortezomib Impurity 22
Cat. No: CL-BTZ-25
CAS No: 94242-81-6
Mol. F: C14H26BNO2 : C2HF3O2
Mol. Wt: 251.2 : 114.0
Inv. Status: Custom Synthesis
Bortezomib Impurity 23
Cat. No: CL-BTZ-26
CAS No: NA
Mol. F: C14H24BClO2
Mol. Wt: 270.6
Inv. Status: Custom Synthesis
Bortezomib Impurity 24
Cat. No: CL-BTZ-27
CAS No: NA
Mol. F: C20H42BNO2Si2
Mol. Wt: 395.6
Inv. Status: Custom Synthesis
Bortezomib Impurity 25
Cat. No: CL-BTZ-28
CAS No: NA
Mol. F: C14H26BNO2
Mol. Wt: 251.2
Inv. Status: Custom Synthesis
Bortezomib Impurity 26
Cat. No: CL-BTZ-29
CAS No: 78-77-3
Mol. F: C4H9Br
Mol. Wt: 137
Inv. Status: Custom Synthesis
Bortezomib Impurity 27
Cat. No: CL-BTZ-30
CAS No: 63-91-2
Mol. F: C9H11NO2
Mol. Wt: 165.2
Inv. Status: Custom Synthesis
Bortezomib Impurity 28
Cat. No: CL-BTZ-31
CAS No: 18942-49-9
Mol. F: C14H19NO4
Mol. Wt: 265.3
Inv. Status: Custom Synthesis
Bortezomib Impurity 29
Cat. No: CL-BTZ-32
CAS No: 89-01-0
Mol. F: C6H4N2O4
Mol. Wt: 168.1
Inv. Status: Custom Synthesis
Bortezomib Impurity 30
Cat. No: CL-BTZ-33
CAS No: 513-36-0
Mol. F: C4H9Cl
Mol. Wt: 92.6
Inv. Status: Custom Synthesis
Bortezomib Impurity 31
Cat. No: CL-BTZ-34
CAS No: 84110-40-7
Mol. F: C4H11BO2
Mol. Wt: 101.9
Inv. Status: In Stock
Bortezomib Impurity 32
Cat. No: CL-BTZ-35
CAS No: 2363753-29-9
Mol. F: C15H28BNO2 : C2HF3O2
Mol. Wt: 265.2 : 114.0
Inv. Status: Custom Synthesis
Bortezomib Impurity 33
Cat. No: CL-BTZ-36
CAS No: 948294-96-0
Mol. F: C14H23BN2O3
Mol. Wt: 278.2
Inv. Status: Custom Synthesis
Bortezomib Impurity 34
Cat. No: CL-BTZ-37
CAS No: NA
Mol. F: C15H14N4O3
Mol. Wt: 298.3
Inv. Status: Custom Synthesis
Bortezomib Impurity 35
Cat. No: CL-BTZ-38
CAS No: NA
Mol. F: C28H34BN5O5
Mol. Wt: 531.4
Inv. Status: Custom Synthesis
Bortezomib Impurity 36
Cat. No: CL-BTZ-39
CAS No: 114457-94-2
Mol. F: C14H13N3O3
Mol. Wt: 271.3
Inv. Status: Custom Synthesis
Bortezomib Related Impurity E
Cat. No: CL-BTZ-40
CAS No: NA
Mol. F: C20H26N4O3
Mol. Wt: 370.5
Inv. Status: Custom Synthesis
Bortezomib Related Impurity F
Cat. No: CL-BTZ-41
CAS No: NA
Mol. F: C20H26N4O3
Mol. Wt: 370.5
Inv. Status: Custom Synthesis
Bortezomib Impurity A
Cat. No: CL-BTZ-42
CAS No: 289472-80-6
Mol. F: C14H14N4O2
Mol. Wt: 270.3
Inv. Status: Custom Synthesis
Bortezomib Impurity C (Mixture Of Isomers)
Cat. No: CL-BTZ-43
CAS No: NA
Mol. F: C19H25BN4O4
Mol. Wt: 384.3
Inv. Status: Custom Synthesis
Bortezomib Impurity F
Cat. No: CL-BTZ-44
CAS No: 73058-37-4
Mol. F: C15H15N3O3
Mol. Wt: 285.3
Inv. Status: Custom Synthesis
Bortezomib Impurity G
Cat. No: CL-BTZ-45
CAS No: 289472-81-7
Mol. F: C19H24N4O3
Mol. Wt: 356.4
Inv. Status: Custom Synthesis
Bortezomib Impurity H
Cat. No: CL-BTZ-46
CAS No: 1446194-56-4
Mol. F: C19H24N4O2
Mol. Wt: 340.4
Inv. Status: Custom Synthesis
Bortezomib Impurity M
Cat. No: CL-BTZ-47
CAS No: NA
Mol. F: C19H24N4O4
Mol. Wt: 372.4
Inv. Status: Custom Synthesis
Bortezomib Impurity N
Cat. No: CL-BTZ-48
CAS No: NA
Mol. F: C19H24N4O4
Mol. Wt: 372.4
Inv. Status: Custom Synthesis
Bortezomib Intermediate(R,S)
Cat. No: CL-BTZ-49
CAS No: 2363753-37-9
Mol. F: C14H25BO2
Mol. Wt: 236.2
Inv. Status: Custom Synthesis
Bortezomib Intermediate(S,R)
Cat. No: CL-BTZ-50
CAS No: 84110-34-9
Mol. F: C14H25BO2
Mol. Wt: 236.2
Inv. Status: Custom Synthesis
Bortezomib R-Hydroperoxide
Cat. No: CL-BTZ-52
CAS No: 886979-78-8
Mol. F: C19H24N4O4
Mol. Wt: 372.4
Inv. Status: Custom Synthesis
Bortezomib S-Hydroperoxide
Cat. No: CL-BTZ-53
CAS No: 886979-81-3
Mol. F: C19H24N4O4
Mol. Wt: 372.4
Inv. Status: Custom Synthesis
Bortezomib Amino R Isomer
Cat. No: CL-BTZ-54
CAS No: 179324-87-9
Mol. F: C15H28BNO2 : C2HF3O2
Mol. Wt: 265.2 : 114.0
Inv. Status: Custom Synthesis
Bortezomib Isoamyl Impurity
Cat. No: CL-BTZ-55
CAS No: 1375004-39-9
Mol. F: C29H39BN4O4
Mol. Wt: 518.5
Inv. Status: Custom Synthesis
Bortezomib Impurity 37
Cat. No: CL-BTZ-56
CAS No: 1798895-16-5
Mol. F: C15H15N3O3
Mol. Wt: 285.3
Inv. Status: Custom Synthesis
Bortezomib Related Compaund E
Cat. No: CL-BTZ-57
CAS No: NA
Mol. F: C15H14N4O3
Mol. Wt: 298.3
Inv. Status: Custom Synthesis
Bortezomib Related Compaund K
Cat. No: CL-BTZ-59
CAS No: NA
Mol. F: C38H47N8O6
Mol. Wt: 711.8
Inv. Status: Custom Synthesis
Bortezomib Related Compaund N
Cat. No: CL-BTZ-60
CAS No: NA
Mol. F: C19H24N4O3
Mol. Wt: 356.4
Inv. Status: Custom Synthesis
Bortezomib Related Compaund P
Cat. No: CL-BTZ-62
CAS No: NA
Mol. F: C28H34BN5O5
Mol. Wt: 531.4
Inv. Status: Custom Synthesis
Bortezomib Impurity 40
Cat. No: CL-BTZ-63
CAS No: 85167-14-2
Mol. F: C15H26BClO2
Mol. Wt: 284.6
Inv. Status: Custom Synthesis
Bortezomib R And S Hydroperoxide
Cat. No: CL-BTZ-64
CAS No: NA
Mol. F: 2(C19H24N4O4)
Mol. Wt: 2(372.4)
Inv. Status: Custom Synthesis
(S,R)-Bortezomib Hydroxyisopentyl Amide Analog
-Bortezomib Hydroxyisopentyl Amide Analog.jpg)
Cat. No: CL-BTZ-65
CAS No: 289472-78-2
Mol. F: C19H24N4O3
Mol. Wt: 356.4
Inv. Status: Custom Synthesis
Bortezomib Related Compound E
Cat. No: CL-BTZ-66
CAS No: NA
Mol. F: C15H14N4O3
Mol. Wt: 298.3
Inv. Status: Custom Synthesis
Bortezomib Related Compound P
Cat. No: CL-BTZ-67
CAS No: NA
Mol. F: C28H34BN5O5
Mol. Wt: 531.4
Inv. Status: Custom Synthesis
(Pyrazine-2-carbonyl)-D-phenylalanine
-D-phenylalanine.jpg)
Cat. No: CL-BTZ-68
CAS No: 1608986-16-8
Mol. F: C14H13N3O3
Mol. Wt: 271.3
Inv. Status: Custom Synthesis
Bortezomib Hydroxy Ketone Analog
Cat. No: CL-BTZ-69
CAS No: 2379402-85-2
Mol. F: C19H22N4O4
Mol. Wt: 370.4
Inv. Status: Custom Synthesis
Bortezomib D-Mannitol Ester
Cat. No: CL-BTZ-70
CAS No: 444576-08-3
Mol. F: C25H35BN4O8
Mol. Wt: 530.4
Inv. Status: Custom Synthesis
Bortezomib Ester Impurity
Cat. No: CL-BTZ-71
CAS No: NA
Mol. F: C29H39BN4O4
Mol. Wt: 518.5
Inv. Status: Custom Synthesis
Bortezomib Impurity B
Cat. No: CL-BTZ-72
CAS No: NA
Mol. F: C28H37BN4O5
Mol. Wt: 520.4
Inv. Status: Custom Synthesis
Desisobutyl-n-butyl Bortezomib
Cat. No: CL-BTZ-73
CAS No: 1104011-35-9
Mol. F: C19H25BN4O4
Mol. Wt: 384.2
Inv. Status: Custom Synthesis
Phenylalanine Dimer Impurity
Cat. No: CL-BTZ-74
CAS No: NA
Mol. F: C22H20N4O4
Mol. Wt: 404.4
Inv. Status: Custom Synthesis
Bortezomib Impurity 38
Cat. No: CL-BTZ-75
CAS No: 18680-27-8
Mol. F: C10H18O2
Mol. Wt: 170.3
Inv. Status: Custom Synthesis
Bortezomib Impurity 41
Cat. No: CL-BTZ-76
CAS No: 514820-48-5
Mol. F: C21H44BNO2Si2
Mol. Wt: 409.6
Inv. Status: Custom Synthesis
Bortezomib Impurity 42 Trifluoroacetate
Cat. No: CL-BTZ-77
CAS No: 477254-69-6
Mol. F: C15H28BNO2 : C2HF3O2
Mol. Wt: 265.2 : 114.0
Inv. Status: Custom Synthesis
Bortezomib Impurity 43
Cat. No: CL-BTZ-78
CAS No: NA
Mol. F: C28H37BN4O4
Mol. Wt: 504.4
Inv. Status: Custom Synthesis
Bortezomib Impurity 44
Cat. No: CL-BTZ-79
CAS No: 2308-61-4
Mol. F: C18H18N2O2
Mol. Wt: 294.4
Inv. Status: Custom Synthesis
Bortezomib Impurity 45
Cat. No: CL-BTZ-80
CAS No: 1255646-95-7
Mol. F: C17H18N2O3
Mol. Wt: 298.3
Inv. Status: Custom Synthesis
Bortezomib Impurity 46
Cat. No: CL-BTZ-81
CAS No: 2577-40-4
Mol. F: C18H20N2O3
Mol. Wt: 312.4
Inv. Status: Custom Synthesis
Bortezomib Impurity 47
Cat. No: CL-BTZ-82
CAS No: 1194235-14-7
Mol. F: C23H22N4O4
Mol. Wt: 418.5
Inv. Status: Custom Synthesis
Bortezomib Impurity 48
Cat. No: CL-BTZ-83
CAS No: NA
Mol. F: C57H69B3N12O9
Mol. Wt: 1098.7
Inv. Status: Custom Synthesis
Bortezomib Impurity 49
Cat. No: CL-BTZ-84
CAS No: NA
Mol. F: C57H69B3N12O9
Mol. Wt: 1098.7
Inv. Status: Custom Synthesis
Bortezomib Impurity 50
Cat. No: CL-BTZ-85
CAS No: NA
Mol. F: C57H69B3N12O9
Mol. Wt: 1098.7
Inv. Status: Custom Synthesis
Bortezomib Impurity 51
Cat. No: CL-BTZ-86
CAS No: NA
Mol. F: C27H35BN4O4
Mol. Wt: 490.4
Inv. Status: Custom Synthesis
Bortezomib Impurity 53
Cat. No: CL-BTZ-87
CAS No: 2364553-64-8
Mol. F: C14H13N3O3
Mol. Wt: 271.3
Inv. Status: Custom Synthesis
Bortezomib Impurity 54
Cat. No: CL-BTZ-88
CAS No: 110755-29-8
Mol. F: C14H22N2O
Mol. Wt: 234.3
Inv. Status: Custom Synthesis
Bortezomib Impurity 56
Cat. No: CL-BTZ-89
CAS No: 4664-57-7
Mol. F: C11H16O3S
Mol. Wt: 228.3
Inv. Status: Custom Synthesis
Bortezomib Impurity 70
Cat. No: CL-BTZ-90
CAS No: NA
Mol. F: C19H25BN4O4
Mol. Wt: 384.2
Inv. Status: Custom Synthesis
Bortezomib Impurity 71
Cat. No: CL-BTZ-91
CAS No: 1579304-37-2
Mol. F: C29H39BN4O4
Mol. Wt: 518.5
Inv. Status: Custom Synthesis
Bortezomib Impurity 72
Cat. No: CL-BTZ-92
CAS No: NA
Mol. F: C22H30N4O4
Mol. Wt: 414.5
Inv. Status: Custom Synthesis
Bortezomib Impurity 73
Cat. No: CL-BTZ-93
CAS No: NA
Mol. F: C22H30N4O4
Mol. Wt: 414.5
Inv. Status: Custom Synthesis
Bortezomib Impurity 74
Cat. No: CL-BTZ-94
CAS No: NA
Mol. F: C22H30N4O4
Mol. Wt: 414.5
Inv. Status: Custom Synthesis
Bortezomib Impurity 76
Cat. No: CL-BTZ-95
CAS No: NA
Mol. F: C19H24N4O2
Mol. Wt: 340.4
Inv. Status: Custom Synthesis
Bortezomib Impurity 77
Cat. No: CL-BTZ-96
CAS No: NA
Mol. F: C19H24N4O3
Mol. Wt: 356.4
Inv. Status: Custom Synthesis
Bortezomib Impurity 78
Cat. No: CL-BTZ-97
CAS No: NA
Mol. F: C21H44BNO2Si2
Mol. Wt: 409.6
Inv. Status: Custom Synthesis
Bortezomib Impurity 79
Cat. No: CL-BTZ-98
CAS No: NA
Mol. F: C29H39BN4O4
Mol. Wt: 518.5
Inv. Status: Custom Synthesis
Bortezomib Impurity 81
Cat. No: CL-BTZ-99
CAS No: NA
Mol. F: C25H36BN5O4
Mol. Wt: 481.4
Inv. Status: Custom Synthesis
Bortezomib Impurity 82
Cat. No: CL-BTZ-100
CAS No: 2304059-57-0
Mol. F: C15H15N3O3
Mol. Wt: 285.3
Inv. Status: Custom Synthesis
Bortezomib D5
Cat. No: CL-BTZ-101
CAS No: 1133706-15-6
Mol. F: C19H20D5BN4O4
Mol. Wt: 389.3
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: